NEW YORK (GenomeWeb) – After three straight years of declining mergers and acquisitions in the molecular diagnostics and omics life science tools space, 2015 was the year M&As came roaring back. The sector saw a 33 percent increase in deals, with Roche continuing the buying spree it started in 2014 and Merck KGaA closing its $17 billion acquisition of Sigma-Aldrich.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.